Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · page 23 of 56
The slide uses a visual timeline/comparison to contrast the competitor's high-frequency, citrate-containing formulation with the company's low-frequency, citrate-free formulation.
Pitch deck · comparison_table · compare_peers · dense density
Slide locked Sign in to view
Slide schematic 6/6
chart 2/2 paragraph 2/2 source-note 1/1 title 1/1
Components 6
bar-horizontal bar-horizontal paragraph paragraph source-note headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1